Kronox Lab (KRONOX)

FairStock Score: 42/100 — MIXED

Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Looking at Kronox Lab, I see a business with excellent capital efficiency but little forward momentum. The company earns a return on equity of 33.52% and a ROCE of 43.82%, figures that would make any owner smile. The balance sheet is fortress-like with a debt-to-equity of just 0.03, and the promoter holding of 74.21% tells me those at the helm have skin in the game. The Piotroski score of 7 out of 9 supports the notion of a fundamentally sound enterprise. Yet as Graham would say, price is what you pay, value is what you get. At ₹129.30, the market capitalises the company at ₹445 crore, translating to a P/E of 17.19 and a P/B of 6.28. For that premium, I expect growth, but sales have risen only 5.25% and profit growth is a meagre 0.92% over the same period. The PEG ratio of 4.12 underlines that I am paying a rich multiple for very little expansion. The dividend yield of 0.42% offers scant compensation while I wait. The latest quarter, with sales of ₹25 crore and net profit of ₹7 crore, shows a strong margin, but a single quarter does not make a trend. This looks like a high-quality but slow-growing business. It may be a fine company, but at this price, the margin of safety is thin. I would wait for either a lower price or evidence that growth is re-accelerating before committing new capital.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer